Back to Results
First PageMeta Content
Anatomical pathology / Circulating tumor cell / Non-small-cell lung carcinoma / TNM staging system / Medicine / Lung cancer / Oncology


An innovative technology for in vivo isolation of circulating tumor cells in non-small cell lung cancer (NSCLC) patients and immunofluorescent detection of ALK protein 4th European Lung Cancer Conference (ELLC-4)
Add to Reading List

Document Date: 2014-05-27 05:41:15


Open Document

File Size: 2,57 MB

Share Result on Facebook

City

Geneva / Poznan / Potsdam / /

Company

W. Dyszkiewicz2 GILUPI GmbH / /

Country

Poland / Germany / /

/

Facility

University of Medical Sciences / /

IndustryTerm

double applications / medical stainless steel wire / /

MedicalCondition

tumor / lung cancer / H3122 lung cancer / disease / NSCLC / non-small cell lung cancer / EpCAMpositive tumor / anaplastic lymphoma kinase protein / Summary Circulating tumor cells / /

MedicalTreatment

cannula / /

Organization

University of Medical Sciences / Department of Thoracic Surgery / International Criminal Court / Department of Clinical Immunology / /

Position

First author / /

Technology

antibodies / /

SocialTag